Top Markets
Coin of the day
Voyager Therapeutics, Inc. Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.

VYGR
Clasificación en acciones #18066
Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating... Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis (ALS), VY-HTT01 for Huntington's disease, and VY-FXN01 for Friedreich's ataxia. Additionally, Voyager is pursuing a Tau program aimed at various tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, alongside initiatives for spinal muscular atrophy. To advance its gene therapy product pipeline, the company has forged strategic collaboration and licensing agreements with key industry players such as Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. These partnerships cover the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and maintains its corporate headquarters in Cambridge, Massachusetts.
Precio por acción
$3.54
Última sincronización: 2026-09-02
Capitalización bursátil
$213.59M
Cambio (1 día)
3.06%
Cambio (1 año)
-3.94%
País
US
Comercio Voyager Therapeutics, Inc. (VYGR)

Categoría

Historial del precio de la acción de Voyager Therapeutics, Inc. (VYGR)
Precio más alto de cierre: $3.48 el 2026-09-01

Precio más bajo de cierre: $21.80 el 2015-11-01
Historial del precio de la acción de Voyager Therapeutics, Inc. desde 2015 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -5.39%
2025 -31.67%
2024 -23.54%
2023 35.12%
2022 105.49%
2021 -64.56%
2020 -41.72%
2019 39.09%
2018 -32.12%
2017 8.56%
2016 -42.81%
2015 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.33 -8.75%
AU
$757.71 6.76%
CH